(Adds background in paragraphs 2-3) Sept 30 (Reuters) – Telehealth firm LifeMD said on Tuesday it would partner with Novo Nordisk to offer its diabetes drug Ozempic at $499 per month to eligible U.S. patients, including insured people whose plans do not cover GLP-1 therapies. Novo offers Ozempic for $499 a month to eligible cash-paying patients via its own pharmacy, NovoCare, and through tie-ups with telehealth platforms. Patients can book virtual visits, complete testing and get medicine shipped with order tracking through LifeMD. (Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Shilpi Majumdar)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Parents can help youngsters regain their motivation by creating successes. Making their progress visible will…
Berlin (dpa) – Bread and baked goods top the list of food items we wind…
Check out these tips to get the best out of your air fryer, from how…
A gene-edited pig kidney kept a man off dialysis for nine months in a world…
Rome (PA Media/dpa) - Cases of diabetes develop earlier and are more severe in women who…
Berlin (dpa) - Municipalities in many places around the globe have at least one dedicated…